nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—islet of Langerhans—obesity	0.0196	0.146	CbGeAlD
Plerixafor—CXCR4—respiratory system—obesity	0.0185	0.138	CbGeAlD
Plerixafor—CXCR4—adrenal cortex—obesity	0.0156	0.116	CbGeAlD
Plerixafor—CXCR4—cardiovascular system—obesity	0.0142	0.106	CbGeAlD
Plerixafor—CXCR4—pituitary gland—obesity	0.0126	0.0934	CbGeAlD
Plerixafor—CXCR4—adipose tissue—obesity	0.0125	0.093	CbGeAlD
Plerixafor—CXCR4—digestive system—obesity	0.0118	0.0876	CbGeAlD
Plerixafor—CXCR4—adrenal gland—obesity	0.0112	0.0835	CbGeAlD
Plerixafor—CXCR4—endocrine gland—obesity	0.00974	0.0724	CbGeAlD
Plerixafor—CXCR4—liver—obesity	0.00878	0.0653	CbGeAlD
Plerixafor—Haematoma—Topiramate—obesity	0.00288	0.00709	CcSEcCtD
Plerixafor—Musculoskeletal pain—Bupropion—obesity	0.00287	0.00708	CcSEcCtD
Plerixafor—Urticaria—Benzphetamine—obesity	0.0028	0.00691	CcSEcCtD
Plerixafor—Erythema—Diethylpropion—obesity	0.0028	0.0069	CcSEcCtD
Plerixafor—Upset stomach—Topiramate—obesity	0.00276	0.00681	CcSEcCtD
Plerixafor—Constipation—Phendimetrazine—obesity	0.00275	0.00677	CcSEcCtD
Plerixafor—Hypersensitivity—Methamphetamine—obesity	0.00269	0.00664	CcSEcCtD
Plerixafor—Dry mouth—Phentermine—obesity	0.00268	0.00661	CcSEcCtD
Plerixafor—Flatulence—Cimetidine—obesity	0.00263	0.00647	CcSEcCtD
Plerixafor—Ill-defined disorder—Diethylpropion—obesity	0.0026	0.00641	CcSEcCtD
Plerixafor—Hypersensitivity—Benzphetamine—obesity	0.0026	0.0064	CcSEcCtD
Plerixafor—Abdominal pain—Phendimetrazine—obesity	0.00254	0.00626	CcSEcCtD
Plerixafor—Malaise—Diethylpropion—obesity	0.00253	0.00623	CcSEcCtD
Plerixafor—Diarrhoea—Methamphetamine—obesity	0.0025	0.00617	CcSEcCtD
Plerixafor—Insomnia—Phenylpropanolamine—obesity	0.00248	0.00612	CcSEcCtD
Plerixafor—Dyspnoea—Phenylpropanolamine—obesity	0.00245	0.00603	CcSEcCtD
Plerixafor—Dizziness—Methamphetamine—obesity	0.00242	0.00596	CcSEcCtD
Plerixafor—Diarrhoea—Benzphetamine—obesity	0.00241	0.00595	CcSEcCtD
Plerixafor—Malaise—Cimetidine—obesity	0.0024	0.00592	CcSEcCtD
Plerixafor—Insomnia—Phentermine—obesity	0.00238	0.00586	CcSEcCtD
Plerixafor—Discomfort—Diethylpropion—obesity	0.00236	0.00581	CcSEcCtD
Plerixafor—Constipation—Phenylpropanolamine—obesity	0.00235	0.00579	CcSEcCtD
Plerixafor—Dizziness—Benzphetamine—obesity	0.00233	0.00575	CcSEcCtD
Plerixafor—Dry mouth—Diethylpropion—obesity	0.00233	0.00575	CcSEcCtD
Plerixafor—Dyspepsia—Phentermine—obesity	0.00231	0.0057	CcSEcCtD
Plerixafor—Headache—Methamphetamine—obesity	0.00229	0.00565	CcSEcCtD
Plerixafor—Arthralgia—Cimetidine—obesity	0.00227	0.00559	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Phentermine—obesity	0.00227	0.00559	CcSEcCtD
Plerixafor—Fatigue—Phentermine—obesity	0.00227	0.00558	CcSEcCtD
Plerixafor—Feeling abnormal—Phenylpropanolamine—obesity	0.00226	0.00558	CcSEcCtD
Plerixafor—Constipation—Phentermine—obesity	0.00225	0.00554	CcSEcCtD
Plerixafor—Hyperhidrosis—Diethylpropion—obesity	0.00221	0.00545	CcSEcCtD
Plerixafor—Headache—Benzphetamine—obesity	0.00221	0.00545	CcSEcCtD
Plerixafor—Diarrhoea—Phendimetrazine—obesity	0.0022	0.00542	CcSEcCtD
Plerixafor—Anaphylactic shock—Cimetidine—obesity	0.00217	0.00536	CcSEcCtD
Plerixafor—Orthostatic hypotension—Sibutramine—obesity	0.00216	0.00532	CcSEcCtD
Plerixafor—Abdominal distension—Orlistat—obesity	0.00213	0.00524	CcSEcCtD
Plerixafor—Dizziness—Phendimetrazine—obesity	0.00213	0.00524	CcSEcCtD
Plerixafor—Nausea—Benzphetamine—obesity	0.00209	0.00516	CcSEcCtD
Plerixafor—Urticaria—Phentermine—obesity	0.00209	0.00514	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Diethylpropion—obesity	0.00208	0.00513	CcSEcCtD
Plerixafor—Abdominal pain—Phentermine—obesity	0.00208	0.00512	CcSEcCtD
Plerixafor—Insomnia—Diethylpropion—obesity	0.00207	0.0051	CcSEcCtD
Plerixafor—Abdominal distension—Sibutramine—obesity	0.00206	0.00507	CcSEcCtD
Plerixafor—Dyspnoea—Diethylpropion—obesity	0.00204	0.00502	CcSEcCtD
Plerixafor—Abdominal discomfort—Orlistat—obesity	0.00202	0.00499	CcSEcCtD
Plerixafor—Hypersensitivity—Phenylpropanolamine—obesity	0.00202	0.00499	CcSEcCtD
Plerixafor—Headache—Phendimetrazine—obesity	0.00201	0.00496	CcSEcCtD
Plerixafor—Dyspepsia—Diethylpropion—obesity	0.00201	0.00496	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Cimetidine—obesity	0.00198	0.00488	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Diethylpropion—obesity	0.00197	0.00486	CcSEcCtD
Plerixafor—Constipation—Diethylpropion—obesity	0.00195	0.00482	CcSEcCtD
Plerixafor—Nausea—Phendimetrazine—obesity	0.00191	0.00471	CcSEcCtD
Plerixafor—Asthenia—Phentermine—obesity	0.00189	0.00465	CcSEcCtD
Plerixafor—Feeling abnormal—Diethylpropion—obesity	0.00188	0.00464	CcSEcCtD
Plerixafor—Orthostatic hypotension—Bupropion—obesity	0.00188	0.00464	CcSEcCtD
Plerixafor—Fatigue—Cimetidine—obesity	0.00187	0.00462	CcSEcCtD
Plerixafor—Constipation—Cimetidine—obesity	0.00186	0.00458	CcSEcCtD
Plerixafor—Musculoskeletal pain—Topiramate—obesity	0.00183	0.00451	CcSEcCtD
Plerixafor—Urticaria—Diethylpropion—obesity	0.00182	0.00448	CcSEcCtD
Plerixafor—Dizziness—Phenylpropanolamine—obesity	0.00182	0.00448	CcSEcCtD
Plerixafor—Diarrhoea—Phentermine—obesity	0.0018	0.00443	CcSEcCtD
Plerixafor—Abdominal distension—Bupropion—obesity	0.00179	0.00442	CcSEcCtD
Plerixafor—Feeling abnormal—Cimetidine—obesity	0.00179	0.00442	CcSEcCtD
Plerixafor—Vomiting—Phenylpropanolamine—obesity	0.00175	0.0043	CcSEcCtD
Plerixafor—Dizziness—Phentermine—obesity	0.00174	0.00428	CcSEcCtD
Plerixafor—Rash—Phenylpropanolamine—obesity	0.00173	0.00427	CcSEcCtD
Plerixafor—Dermatitis—Phenylpropanolamine—obesity	0.00173	0.00426	CcSEcCtD
Plerixafor—Abdominal discomfort—Bupropion—obesity	0.00171	0.00421	CcSEcCtD
Plerixafor—Haemoglobin—Orlistat—obesity	0.0017	0.00419	CcSEcCtD
Plerixafor—Haemorrhage—Orlistat—obesity	0.00169	0.00417	CcSEcCtD
Plerixafor—Vomiting—Phentermine—obesity	0.00167	0.00412	CcSEcCtD
Plerixafor—Rash—Phentermine—obesity	0.00166	0.00408	CcSEcCtD
Plerixafor—Dermatitis—Phentermine—obesity	0.00166	0.00408	CcSEcCtD
Plerixafor—Headache—Phentermine—obesity	0.00165	0.00406	CcSEcCtD
Plerixafor—Haemoglobin—Sibutramine—obesity	0.00164	0.00405	CcSEcCtD
Plerixafor—Haemorrhage—Sibutramine—obesity	0.00164	0.00403	CcSEcCtD
Plerixafor—Nausea—Phenylpropanolamine—obesity	0.00163	0.00402	CcSEcCtD
Plerixafor—Hypersensitivity—Cimetidine—obesity	0.0016	0.00395	CcSEcCtD
Plerixafor—Diarrhoea—Diethylpropion—obesity	0.00156	0.00385	CcSEcCtD
Plerixafor—Nausea—Phentermine—obesity	0.00156	0.00385	CcSEcCtD
Plerixafor—Asthenia—Cimetidine—obesity	0.00156	0.00385	CcSEcCtD
Plerixafor—Immune system disorder—Orlistat—obesity	0.00153	0.00376	CcSEcCtD
Plerixafor—Dizziness—Diethylpropion—obesity	0.00151	0.00373	CcSEcCtD
Plerixafor—Diarrhoea—Cimetidine—obesity	0.00149	0.00367	CcSEcCtD
Plerixafor—Mental disorder—Orlistat—obesity	0.00148	0.00365	CcSEcCtD
Plerixafor—Immune system disorder—Sibutramine—obesity	0.00148	0.00364	CcSEcCtD
Plerixafor—Vomiting—Diethylpropion—obesity	0.00145	0.00358	CcSEcCtD
Plerixafor—Flatulence—Orlistat—obesity	0.00145	0.00357	CcSEcCtD
Plerixafor—Rash—Diethylpropion—obesity	0.00144	0.00355	CcSEcCtD
Plerixafor—Dermatitis—Diethylpropion—obesity	0.00144	0.00355	CcSEcCtD
Plerixafor—Dizziness—Cimetidine—obesity	0.00144	0.00354	CcSEcCtD
Plerixafor—Haemoglobin—Bupropion—obesity	0.00143	0.00353	CcSEcCtD
Plerixafor—Headache—Diethylpropion—obesity	0.00143	0.00353	CcSEcCtD
Plerixafor—Haemorrhage—Bupropion—obesity	0.00143	0.00351	CcSEcCtD
Plerixafor—Flatulence—Sibutramine—obesity	0.0014	0.00346	CcSEcCtD
Plerixafor—Connective tissue disorder—Bupropion—obesity	0.0014	0.00345	CcSEcCtD
Plerixafor—Vomiting—Cimetidine—obesity	0.00138	0.00341	CcSEcCtD
Plerixafor—Rash—Cimetidine—obesity	0.00137	0.00338	CcSEcCtD
Plerixafor—Dermatitis—Cimetidine—obesity	0.00137	0.00338	CcSEcCtD
Plerixafor—Ill-defined disorder—Orlistat—obesity	0.00136	0.00336	CcSEcCtD
Plerixafor—Headache—Cimetidine—obesity	0.00136	0.00336	CcSEcCtD
Plerixafor—Nausea—Diethylpropion—obesity	0.00136	0.00335	CcSEcCtD
Plerixafor—Malaise—Orlistat—obesity	0.00133	0.00327	CcSEcCtD
Plerixafor—Ill-defined disorder—Sibutramine—obesity	0.00132	0.00326	CcSEcCtD
Plerixafor—Nausea—Cimetidine—obesity	0.00129	0.00318	CcSEcCtD
Plerixafor—Immune system disorder—Bupropion—obesity	0.00129	0.00317	CcSEcCtD
Plerixafor—Malaise—Sibutramine—obesity	0.00128	0.00316	CcSEcCtD
Plerixafor—Syncope—Sibutramine—obesity	0.00128	0.00315	CcSEcCtD
Plerixafor—Loss of consciousness—Sibutramine—obesity	0.00125	0.00308	CcSEcCtD
Plerixafor—Mental disorder—Bupropion—obesity	0.00125	0.00308	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00124	0.00307	CcSEcCtD
Plerixafor—Discomfort—Orlistat—obesity	0.00124	0.00305	CcSEcCtD
Plerixafor—Dry mouth—Orlistat—obesity	0.00122	0.00302	CcSEcCtD
Plerixafor—Flatulence—Bupropion—obesity	0.00122	0.00301	CcSEcCtD
Plerixafor—Arthralgia—Sibutramine—obesity	0.00121	0.00299	CcSEcCtD
Plerixafor—Anaphylactic shock—Orlistat—obesity	0.0012	0.00296	CcSEcCtD
Plerixafor—Orthostatic hypotension—Topiramate—obesity	0.0012	0.00296	CcSEcCtD
Plerixafor—Discomfort—Sibutramine—obesity	0.0012	0.00295	CcSEcCtD
Plerixafor—Dry mouth—Sibutramine—obesity	0.00119	0.00292	CcSEcCtD
Plerixafor—Nervous system disorder—Orlistat—obesity	0.00118	0.0029	CcSEcCtD
Plerixafor—Skin disorder—Orlistat—obesity	0.00117	0.00287	CcSEcCtD
Plerixafor—Anaphylactic shock—Sibutramine—obesity	0.00116	0.00286	CcSEcCtD
Plerixafor—Hyperhidrosis—Orlistat—obesity	0.00116	0.00286	CcSEcCtD
Plerixafor—Ill-defined disorder—Bupropion—obesity	0.00115	0.00284	CcSEcCtD
Plerixafor—Shock—Sibutramine—obesity	0.00114	0.00282	CcSEcCtD
Plerixafor—Abdominal distension—Topiramate—obesity	0.00114	0.00282	CcSEcCtD
Plerixafor—Skin disorder—Sibutramine—obesity	0.00113	0.00278	CcSEcCtD
Plerixafor—Hyperhidrosis—Sibutramine—obesity	0.00112	0.00277	CcSEcCtD
Plerixafor—Malaise—Bupropion—obesity	0.00112	0.00276	CcSEcCtD
Plerixafor—Syncope—Bupropion—obesity	0.00111	0.00274	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Orlistat—obesity	0.00109	0.0027	CcSEcCtD
Plerixafor—Loss of consciousness—Bupropion—obesity	0.00109	0.00269	CcSEcCtD
Plerixafor—Abdominal discomfort—Topiramate—obesity	0.00109	0.00268	CcSEcCtD
Plerixafor—Insomnia—Orlistat—obesity	0.00109	0.00268	CcSEcCtD
Plerixafor—Paraesthesia—Orlistat—obesity	0.00108	0.00266	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Sibutramine—obesity	0.00106	0.00261	CcSEcCtD
Plerixafor—Dyspepsia—Orlistat—obesity	0.00106	0.00261	CcSEcCtD
Plerixafor—Arthralgia—Bupropion—obesity	0.00106	0.0026	CcSEcCtD
Plerixafor—Insomnia—Sibutramine—obesity	0.00105	0.00259	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00105	0.00259	CcSEcCtD
Plerixafor—Discomfort—Bupropion—obesity	0.00104	0.00257	CcSEcCtD
Plerixafor—Paraesthesia—Sibutramine—obesity	0.00104	0.00257	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Orlistat—obesity	0.00104	0.00256	CcSEcCtD
Plerixafor—Dyspnoea—Sibutramine—obesity	0.00104	0.00255	CcSEcCtD
Plerixafor—Fatigue—Orlistat—obesity	0.00104	0.00255	CcSEcCtD
Plerixafor—Dry mouth—Bupropion—obesity	0.00103	0.00255	CcSEcCtD
Plerixafor—Pain—Orlistat—obesity	0.00103	0.00253	CcSEcCtD
Plerixafor—Dyspepsia—Sibutramine—obesity	0.00102	0.00252	CcSEcCtD
Plerixafor—Anaphylactic shock—Bupropion—obesity	0.00101	0.0025	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Sibutramine—obesity	0.001	0.00247	CcSEcCtD
Plerixafor—Shock—Bupropion—obesity	0.000997	0.00246	CcSEcCtD
Plerixafor—Pain—Sibutramine—obesity	0.000994	0.00245	CcSEcCtD
Plerixafor—Constipation—Sibutramine—obesity	0.000994	0.00245	CcSEcCtD
Plerixafor—Nervous system disorder—Bupropion—obesity	0.000993	0.00245	CcSEcCtD
Plerixafor—Feeling abnormal—Orlistat—obesity	0.000989	0.00244	CcSEcCtD
Plerixafor—Skin disorder—Bupropion—obesity	0.000984	0.00243	CcSEcCtD
Plerixafor—Gastrointestinal pain—Orlistat—obesity	0.000982	0.00242	CcSEcCtD
Plerixafor—Hyperhidrosis—Bupropion—obesity	0.000979	0.00241	CcSEcCtD
Plerixafor—Feeling abnormal—Sibutramine—obesity	0.000958	0.00236	CcSEcCtD
Plerixafor—Urticaria—Orlistat—obesity	0.000954	0.00235	CcSEcCtD
Plerixafor—Gastrointestinal pain—Sibutramine—obesity	0.00095	0.00234	CcSEcCtD
Plerixafor—Abdominal pain—Orlistat—obesity	0.000949	0.00234	CcSEcCtD
Plerixafor—Urticaria—Sibutramine—obesity	0.000923	0.00228	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Bupropion—obesity	0.000923	0.00227	CcSEcCtD
Plerixafor—Abdominal pain—Sibutramine—obesity	0.000919	0.00226	CcSEcCtD
Plerixafor—Insomnia—Bupropion—obesity	0.000916	0.00226	CcSEcCtD
Plerixafor—Haemoglobin—Topiramate—obesity	0.000913	0.00225	CcSEcCtD
Plerixafor—Paraesthesia—Bupropion—obesity	0.00091	0.00224	CcSEcCtD
Plerixafor—Haemorrhage—Topiramate—obesity	0.000908	0.00224	CcSEcCtD
Plerixafor—Dyspnoea—Bupropion—obesity	0.000903	0.00223	CcSEcCtD
Plerixafor—Connective tissue disorder—Topiramate—obesity	0.000893	0.0022	CcSEcCtD
Plerixafor—Dyspepsia—Bupropion—obesity	0.000892	0.0022	CcSEcCtD
Plerixafor—Hypersensitivity—Orlistat—obesity	0.000885	0.00218	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Bupropion—obesity	0.000875	0.00216	CcSEcCtD
Plerixafor—Fatigue—Bupropion—obesity	0.000873	0.00215	CcSEcCtD
Plerixafor—Constipation—Bupropion—obesity	0.000866	0.00214	CcSEcCtD
Plerixafor—Pain—Bupropion—obesity	0.000866	0.00214	CcSEcCtD
Plerixafor—Asthenia—Orlistat—obesity	0.000861	0.00212	CcSEcCtD
Plerixafor—Hypersensitivity—Sibutramine—obesity	0.000856	0.00211	CcSEcCtD
Plerixafor—Pruritus—Orlistat—obesity	0.000849	0.00209	CcSEcCtD
Plerixafor—Feeling abnormal—Bupropion—obesity	0.000835	0.00206	CcSEcCtD
Plerixafor—Asthenia—Sibutramine—obesity	0.000834	0.00206	CcSEcCtD
Plerixafor—Gastrointestinal pain—Bupropion—obesity	0.000828	0.00204	CcSEcCtD
Plerixafor—Pruritus—Sibutramine—obesity	0.000822	0.00203	CcSEcCtD
Plerixafor—Diarrhoea—Orlistat—obesity	0.000821	0.00202	CcSEcCtD
Plerixafor—Immune system disorder—Topiramate—obesity	0.000821	0.00202	CcSEcCtD
Plerixafor—Urticaria—Bupropion—obesity	0.000805	0.00198	CcSEcCtD
Plerixafor—Abdominal pain—Bupropion—obesity	0.000801	0.00197	CcSEcCtD
Plerixafor—Mental disorder—Topiramate—obesity	0.000796	0.00196	CcSEcCtD
Plerixafor—Diarrhoea—Sibutramine—obesity	0.000795	0.00196	CcSEcCtD
Plerixafor—Dizziness—Orlistat—obesity	0.000794	0.00196	CcSEcCtD
Plerixafor—Erythema—Topiramate—obesity	0.000791	0.00195	CcSEcCtD
Plerixafor—Flatulence—Topiramate—obesity	0.000779	0.00192	CcSEcCtD
Plerixafor—Dizziness—Sibutramine—obesity	0.000768	0.00189	CcSEcCtD
Plerixafor—Vomiting—Orlistat—obesity	0.000763	0.00188	CcSEcCtD
Plerixafor—Rash—Orlistat—obesity	0.000757	0.00187	CcSEcCtD
Plerixafor—Dermatitis—Orlistat—obesity	0.000756	0.00186	CcSEcCtD
Plerixafor—Headache—Orlistat—obesity	0.000752	0.00185	CcSEcCtD
Plerixafor—Hypersensitivity—Bupropion—obesity	0.000746	0.00184	CcSEcCtD
Plerixafor—Vomiting—Sibutramine—obesity	0.000739	0.00182	CcSEcCtD
Plerixafor—Ill-defined disorder—Topiramate—obesity	0.000734	0.00181	CcSEcCtD
Plerixafor—Rash—Sibutramine—obesity	0.000733	0.00181	CcSEcCtD
Plerixafor—Dermatitis—Sibutramine—obesity	0.000732	0.0018	CcSEcCtD
Plerixafor—Headache—Sibutramine—obesity	0.000728	0.00179	CcSEcCtD
Plerixafor—Asthenia—Bupropion—obesity	0.000727	0.00179	CcSEcCtD
Plerixafor—Pruritus—Bupropion—obesity	0.000717	0.00177	CcSEcCtD
Plerixafor—Nausea—Orlistat—obesity	0.000713	0.00176	CcSEcCtD
Plerixafor—Malaise—Topiramate—obesity	0.000713	0.00176	CcSEcCtD
Plerixafor—Syncope—Topiramate—obesity	0.000709	0.00175	CcSEcCtD
Plerixafor—Loss of consciousness—Topiramate—obesity	0.000695	0.00171	CcSEcCtD
Plerixafor—Diarrhoea—Bupropion—obesity	0.000693	0.00171	CcSEcCtD
Plerixafor—Nausea—Sibutramine—obesity	0.00069	0.0017	CcSEcCtD
Plerixafor—Arthralgia—Topiramate—obesity	0.000673	0.00166	CcSEcCtD
Plerixafor—Dizziness—Bupropion—obesity	0.00067	0.00165	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000669	0.00165	CcSEcCtD
Plerixafor—Discomfort—Topiramate—obesity	0.000665	0.00164	CcSEcCtD
Plerixafor—Dry mouth—Topiramate—obesity	0.000658	0.00162	CcSEcCtD
Plerixafor—Vomiting—Bupropion—obesity	0.000644	0.00159	CcSEcCtD
Plerixafor—Rash—Bupropion—obesity	0.000639	0.00157	CcSEcCtD
Plerixafor—Dermatitis—Bupropion—obesity	0.000638	0.00157	CcSEcCtD
Plerixafor—Shock—Topiramate—obesity	0.000635	0.00157	CcSEcCtD
Plerixafor—Headache—Bupropion—obesity	0.000635	0.00156	CcSEcCtD
Plerixafor—Nervous system disorder—Topiramate—obesity	0.000633	0.00156	CcSEcCtD
Plerixafor—Skin disorder—Topiramate—obesity	0.000627	0.00155	CcSEcCtD
Plerixafor—Hyperhidrosis—Topiramate—obesity	0.000624	0.00154	CcSEcCtD
Plerixafor—Nausea—Bupropion—obesity	0.000602	0.00148	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Topiramate—obesity	0.000588	0.00145	CcSEcCtD
Plerixafor—Insomnia—Topiramate—obesity	0.000584	0.00144	CcSEcCtD
Plerixafor—Paraesthesia—Topiramate—obesity	0.00058	0.00143	CcSEcCtD
Plerixafor—Dyspnoea—Topiramate—obesity	0.000575	0.00142	CcSEcCtD
Plerixafor—Dyspepsia—Topiramate—obesity	0.000568	0.0014	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Topiramate—obesity	0.000557	0.00137	CcSEcCtD
Plerixafor—Fatigue—Topiramate—obesity	0.000556	0.00137	CcSEcCtD
Plerixafor—Pain—Topiramate—obesity	0.000552	0.00136	CcSEcCtD
Plerixafor—Constipation—Topiramate—obesity	0.000552	0.00136	CcSEcCtD
Plerixafor—Feeling abnormal—Topiramate—obesity	0.000532	0.00131	CcSEcCtD
Plerixafor—Gastrointestinal pain—Topiramate—obesity	0.000528	0.0013	CcSEcCtD
Plerixafor—Urticaria—Topiramate—obesity	0.000513	0.00126	CcSEcCtD
Plerixafor—Abdominal pain—Topiramate—obesity	0.00051	0.00126	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—ADRB3—obesity	0.000489	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FFAR4—obesity	0.000486	0.00106	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HDAC8—obesity	0.000485	0.00105	CbGpPWpGaD
Plerixafor—CXCR4—CXCR4-mediated signaling events—AKT1—obesity	0.000484	0.00105	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GAL—obesity	0.000477	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—GNAS—obesity	0.000477	0.00104	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCK—obesity	0.000475	0.00103	CbGpPWpGaD
Plerixafor—Hypersensitivity—Topiramate—obesity	0.000475	0.00117	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—C5AR1—obesity	0.000472	0.00103	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MCHR1—obesity	0.000466	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GHSR—obesity	0.000466	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BRS3—obesity	0.000466	0.00101	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GLP1R—obesity	0.000463	0.00101	CbGpPWpGaD
Plerixafor—Asthenia—Topiramate—obesity	0.000463	0.00114	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—F2—obesity	0.000463	0.00101	CbGpPWpGaD
Plerixafor—Pruritus—Topiramate—obesity	0.000457	0.00113	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—CCL5—obesity	0.000456	0.000992	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCKAR—obesity	0.000456	0.000991	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HRH3—obesity	0.000456	0.000991	CbGpPWpGaD
Plerixafor—Diarrhoea—Topiramate—obesity	0.000442	0.00109	CcSEcCtD
Plerixafor—CXCR4—Disease—PCK1—obesity	0.00044	0.000958	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SH2B1—obesity	0.000433	0.000941	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GH1—obesity	0.000433	0.000941	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRLHR—obesity	0.000433	0.000941	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCK—obesity	0.000432	0.000939	CbGpPWpGaD
Plerixafor—CXCR4—Disease—ACP5—obesity	0.000428	0.000932	CbGpPWpGaD
Plerixafor—Dizziness—Topiramate—obesity	0.000427	0.00105	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—POMC—obesity	0.000422	0.000917	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GLP1R—obesity	0.000421	0.000915	CbGpPWpGaD
Plerixafor—CXCR4—Disease—G6PD—obesity	0.000417	0.000908	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCKAR—obesity	0.000414	0.0009	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HRH3—obesity	0.000414	0.0009	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPY—obesity	0.000413	0.000898	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—CCL2—obesity	0.000413	0.000897	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HK1—obesity	0.000412	0.000897	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—IAPP—obesity	0.00041	0.000893	CbGpPWpGaD
Plerixafor—Vomiting—Topiramate—obesity	0.00041	0.00101	CcSEcCtD
Plerixafor—Rash—Topiramate—obesity	0.000407	0.001	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—PYY—obesity	0.000407	0.000885	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APLN—obesity	0.000407	0.000885	CbGpPWpGaD
Plerixafor—Dermatitis—Topiramate—obesity	0.000407	0.001	CcSEcCtD
Plerixafor—Headache—Topiramate—obesity	0.000404	0.000997	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—HTR2A—obesity	0.000402	0.000875	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—C3—obesity	0.000402	0.000873	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKAR2B—obesity	0.000398	0.000867	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR1B—obesity	0.000398	0.000867	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CRH—obesity	0.000398	0.000867	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PNLIP—obesity	0.000386	0.000839	CbGpPWpGaD
Plerixafor—Nausea—Topiramate—obesity	0.000383	0.000945	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—AGT—obesity	0.000382	0.00083	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—NPS—obesity	0.000378	0.000822	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SDC3—obesity	0.000377	0.000819	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPY—obesity	0.000375	0.000816	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IAPP—obesity	0.000373	0.000811	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—DRD1—obesity	0.00037	0.000806	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2C—obesity	0.00037	0.000806	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY5R—obesity	0.000368	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PMCH—obesity	0.000368	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NMU—obesity	0.000368	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HCRT—obesity	0.000368	0.0008	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR1B—obesity	0.000362	0.000787	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CRH—obesity	0.000362	0.000787	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB1—obesity	0.000359	0.00078	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RBP4—obesity	0.000355	0.000772	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MC3R—obesity	0.000353	0.000767	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MC4R—obesity	0.000353	0.000767	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY2R—obesity	0.000353	0.000767	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY1R—obesity	0.000353	0.000767	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—F2—obesity	0.000353	0.000767	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GHRL—obesity	0.000351	0.000764	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—DRD4—obesity	0.000348	0.000757	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PPY—obesity	0.000346	0.000753	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—NPS—obesity	0.000343	0.000746	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HDAC8—obesity	0.00034	0.000739	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCH—obesity	0.00034	0.000739	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GIP—obesity	0.00034	0.000739	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—DRD1—obesity	0.000336	0.000732	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2C—obesity	0.000336	0.000732	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKAR2B—obesity	0.000336	0.000731	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CST3—obesity	0.000336	0.000731	CbGpPWpGaD
Plerixafor—CXCR4—Disease—DCN—obesity	0.000334	0.000726	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CNR1—obesity	0.000333	0.000723	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRB1—obesity	0.000326	0.000709	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NCF2—obesity	0.000325	0.000706	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—DRD2—obesity	0.000324	0.000706	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEPR—obesity	0.000323	0.000702	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GCG—obesity	0.000321	0.000699	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—POMC—obesity	0.000321	0.000698	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GHRL—obesity	0.000319	0.000694	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NAMPT—obesity	0.000318	0.000692	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GCK—obesity	0.000316	0.000688	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—DRD4—obesity	0.000316	0.000688	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IAPP—obesity	0.000314	0.000684	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOC3—obesity	0.000314	0.000684	CbGpPWpGaD
Plerixafor—CXCR4—GPCR ligand binding—CCL2—obesity	0.000314	0.000683	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CNR1—obesity	0.000302	0.000657	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SDC1—obesity	0.000302	0.000656	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKR1C3—obesity	0.000297	0.000646	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—DRD2—obesity	0.000295	0.000641	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GCG—obesity	0.000292	0.000634	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—ADRB2—obesity	0.000291	0.000632	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB3—obesity	0.000289	0.000628	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GAL—obesity	0.000282	0.000613	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C5AR1—obesity	0.000279	0.000607	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GNB3—obesity	0.000277	0.000602	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT2—obesity	0.000276	0.0006	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FASN—obesity	0.00027	0.000588	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—GNAS—obesity	0.00027	0.000586	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PARP1—obesity	0.000269	0.000585	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—ADRB2—obesity	0.000264	0.000574	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—CCL5—obesity	0.000258	0.000561	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKG1—obesity	0.000255	0.000555	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCK—obesity	0.000255	0.000555	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS1—obesity	0.000253	0.00055	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNB3—obesity	0.000251	0.000547	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TCF7L2—obesity	0.00025	0.000544	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RBP4—obesity	0.000249	0.000541	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GLP1R—obesity	0.000249	0.000541	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SLC2A4—obesity	0.000246	0.000535	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—GNAS—obesity	0.000245	0.000532	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRH3—obesity	0.000245	0.000532	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCKAR—obesity	0.000245	0.000532	CbGpPWpGaD
Plerixafor—CXCR4—Disease—GOT1—obesity	0.000238	0.000518	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKAR2B—obesity	0.000235	0.000512	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRL—obesity	0.000235	0.00051	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL5—obesity	0.000234	0.000509	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCD—obesity	0.000232	0.000505	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NCF2—obesity	0.000227	0.000494	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—HTR2A—obesity	0.000227	0.000494	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—C3—obesity	0.000227	0.000494	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FOXO3—obesity	0.000223	0.000486	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPY—obesity	0.000222	0.000482	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IAPP—obesity	0.00022	0.000479	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOC3—obesity	0.00022	0.000479	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AGT—obesity	0.000216	0.000469	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR1B—obesity	0.000214	0.000465	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CRH—obesity	0.000214	0.000465	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SDC1—obesity	0.000211	0.00046	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCD—obesity	0.000211	0.000459	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKR1C3—obesity	0.000208	0.000452	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HTR2A—obesity	0.000206	0.000449	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—C3—obesity	0.000206	0.000448	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NPS—obesity	0.000203	0.000441	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOB—obesity	0.000202	0.00044	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PRKCB—obesity	0.000199	0.000433	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—F2—obesity	0.000199	0.000433	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2C—obesity	0.000199	0.000432	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DRD1—obesity	0.000199	0.000432	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AGT—obesity	0.000196	0.000426	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NTRK2—obesity	0.000193	0.00042	CbGpPWpGaD
Plerixafor—CXCR4—Disease—LPL—obesity	0.000193	0.00042	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB1—obesity	0.000192	0.000419	CbGpPWpGaD
Plerixafor—CXCR4—Disease—FOXO1—obesity	0.000192	0.000417	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CG—obesity	0.000191	0.000415	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GHRL—obesity	0.000188	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PARP1—obesity	0.000188	0.00041	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DRD4—obesity	0.000187	0.000406	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—POMC—obesity	0.000181	0.000395	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—F2—obesity	0.000181	0.000393	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PRKCB—obesity	0.000181	0.000393	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CNR1—obesity	0.000178	0.000388	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PRKCD—obesity	0.000178	0.000387	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TCF7L2—obesity	0.000175	0.000381	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT2—obesity	0.000174	0.000379	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—DRD2—obesity	0.000174	0.000379	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTHFR—obesity	0.000174	0.000378	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CG—obesity	0.000173	0.000377	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GCG—obesity	0.000172	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PTPN1—obesity	0.000172	0.000375	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CD—obesity	0.000168	0.000365	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS2—obesity	0.000165	0.00036	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—POMC—obesity	0.000165	0.000358	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRL—obesity	0.000164	0.000357	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STK11—obesity	0.000162	0.000352	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOE—obesity	0.000162	0.000352	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—CCL2—obesity	0.000161	0.000351	CbGpPWpGaD
Plerixafor—CXCR4—Disease—CAV1—obesity	0.00016	0.000349	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PLG—obesity	0.00016	0.000348	CbGpPWpGaD
Plerixafor—CXCR4—Disease—APOA1—obesity	0.00016	0.000348	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—RHOA—obesity	0.00016	0.000348	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT2—obesity	0.000158	0.000345	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3R1—obesity	0.000158	0.000344	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FOXO3—obesity	0.000156	0.00034	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ADRB2—obesity	0.000156	0.000339	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SOCS1—obesity	0.000154	0.000334	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CD—obesity	0.000152	0.000331	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SOCS3—obesity	0.000152	0.00033	CbGpPWpGaD
Plerixafor—CXCR4—Disease—BAD—obesity	0.000151	0.000328	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNB3—obesity	0.000149	0.000323	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—TYK2—obesity	0.000146	0.000318	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CB—obesity	0.000146	0.000318	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF2—obesity	0.000146	0.000317	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—RHOA—obesity	0.000145	0.000316	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—GNAS—obesity	0.000145	0.000314	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IRS1—obesity	0.000144	0.000314	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3R1—obesity	0.000144	0.000313	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOB—obesity	0.000142	0.000308	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL5—obesity	0.000138	0.000301	CbGpPWpGaD
Plerixafor—CXCR4—Disease—INS—obesity	0.000138	0.000301	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LPL—obesity	0.000135	0.000294	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—FOXO1—obesity	0.000134	0.000292	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RPS6KB1—obesity	0.000134	0.000291	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT2—obesity	0.000134	0.000291	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CB—obesity	0.000133	0.000289	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CD—obesity	0.000128	0.000279	CbGpPWpGaD
Plerixafor—CXCR4—Disease—SERPINE1—obesity	0.000127	0.000276	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCD—obesity	0.000125	0.000271	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TYK2—obesity	0.000124	0.000269	CbGpPWpGaD
Plerixafor—CXCR4—Disease—RHOA—obesity	0.000123	0.000266	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HTR2A—obesity	0.000122	0.000265	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—C3—obesity	0.000122	0.000265	CbGpPWpGaD
Plerixafor—CXCR4—Disease—NOS3—obesity	0.000121	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3R1—obesity	0.000121	0.000264	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS2—obesity	0.000116	0.000252	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AGT—obesity	0.000116	0.000252	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOE—obesity	0.000113	0.000246	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—LEP—obesity	0.000113	0.000246	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CAV1—obesity	0.000112	0.000244	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—APOA1—obesity	0.000112	0.000244	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MTOR—obesity	0.000112	0.000243	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CB—obesity	0.000112	0.000243	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PTGS2—obesity	0.000111	0.000241	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—ESR1—obesity	0.000108	0.000235	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PRKCB—obesity	0.000107	0.000232	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—F2—obesity	0.000107	0.000232	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—BAD—obesity	0.000106	0.00023	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CG—obesity	0.000102	0.000222	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IRS1—obesity	0.000101	0.00022	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—POMC—obesity	9.74e-05	0.000212	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—INS—obesity	9.68e-05	0.000211	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—CCL2—obesity	9.53e-05	0.000207	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IGF1—obesity	9.36e-05	0.000204	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT2—obesity	9.36e-05	0.000204	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CD—obesity	8.99e-05	0.000196	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—PIK3CA—obesity	8.91e-05	0.000194	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—SERPINE1—obesity	8.89e-05	0.000193	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TYK2—obesity	8.65e-05	0.000188	CbGpPWpGaD
Plerixafor—CXCR4—Disease—STAT3—obesity	8.65e-05	0.000188	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—RHOA—obesity	8.58e-05	0.000187	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—NOS3—obesity	8.49e-05	0.000185	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3R1—obesity	8.49e-05	0.000185	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—PIK3CA—obesity	8.09e-05	0.000176	CbGpPWpGaD
Plerixafor—CXCR4—Disease—MYC—obesity	8.04e-05	0.000175	CbGpPWpGaD
Plerixafor—CXCR4—Disease—TGFB1—obesity	8.02e-05	0.000174	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MTOR—obesity	7.84e-05	0.00017	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CB—obesity	7.84e-05	0.00017	CbGpPWpGaD
Plerixafor—CXCR4—GPCR downstream signaling—AKT1—obesity	7.28e-05	0.000158	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—IL6—obesity	7.16e-05	0.000156	CbGpPWpGaD
Plerixafor—CXCR4—Disease—PIK3CA—obesity	6.82e-05	0.000148	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MMP9—obesity	6.81e-05	0.000148	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MAPK8—obesity	6.62e-05	0.000144	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—AKT1—obesity	6.61e-05	0.000144	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—STAT3—obesity	6.06e-05	0.000132	CbGpPWpGaD
Plerixafor—CXCR4—Disease—IL6—obesity	6.04e-05	0.000131	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—obesity	5.63e-05	0.000122	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TGFB1—obesity	5.61e-05	0.000122	CbGpPWpGaD
Plerixafor—CXCR4—Disease—AKT1—obesity	5.57e-05	0.000121	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—PIK3CA—obesity	4.78e-05	0.000104	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—IL6—obesity	4.23e-05	9.2e-05	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AKT1—obesity	3.9e-05	8.49e-05	CbGpPWpGaD
